Tate-Ostroff B, Majocha R E, Walcott E C, Ventosa-Michelman M, Marotta C A
Department of Psychiatry, Harvard Medical School, Boston, MA.
J Geriatr Psychiatry Neurol. 1990 Jul-Sep;3(3):139-45. doi: 10.1177/089198879000300303.
The mechanism by which the A4 (beta-amyloid) domain of the Alzheimer amyloid precursor protein (APP) is deposited in plaques is unknown, and limited information is available concerning the extent to which other APP sites are associated with plaques. To address these issues, we prepared antiserum to a peptide adjacent to the N-terminus of the APP (referred to as N1) and examined its distribution in brain relative to A4 by double-immunostaining techniques. Anti-N1 localized to both neurons and glia in control and Alzheimer patients. In the Alzheimer brain, anti-N1 detected plaques. Quantitation revealed that 85% of thioflavin-positive plaques, and 91% of A4-positive plaques were also N1 positive. Double-staining methods directly demonstrated colocalization of distant APP sites. The data suggest that suggest that proposed mechanisms for amyloid deposition during plaque formation must take into account the extracytoplasmic domain, in addition to the A4 region, rather than be confined exclusively to the A4 site.
阿尔茨海默病淀粉样前体蛋白(APP)的A4(β-淀粉样蛋白)结构域在斑块中沉积的机制尚不清楚,关于其他APP位点与斑块关联程度的信息也有限。为了解决这些问题,我们制备了针对APP N端相邻肽段(称为N1)的抗血清,并通过双重免疫染色技术研究了其在脑中相对于A4的分布。在对照和阿尔茨海默病患者中,抗N1定位于神经元和神经胶质细胞。在阿尔茨海默病脑中,抗N1检测到斑块。定量分析显示,85%的硫黄素阳性斑块和91%的A4阳性斑块也是N1阳性。双重染色方法直接证明了APP不同位点的共定位。数据表明,在斑块形成过程中,除了A4区域外,淀粉样蛋白沉积的假定机制必须考虑胞外结构域,而不是仅局限于A4位点。